Rocket Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RCKT research report →
About the company
Rocket Pharmaceuticals, Inc. , operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs.
- CEO
- Gaurav D. Shah
- IPO
- 2015
- Employees
- 299
- HQ
- Cranbury, NJ, US
Price Chart
- Market Cap
- $419.30M
- P/E
- -2.05
- P/S
- 0.00
- P/B
- 1.81
- EV/EBITDA
- -2.03
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -70.79%
- ROIC
- -81.81%
- Revenue
- $0 · 0.00%
- Net Income
- $-223,123,000 · 13.77%
- EPS
- $-2.01 · 26.37%
- Op Income
- $-228,516,000
- FCF YoY
- 11.66%
- 52W High
- $5.45
- 52W Low
- $2.53
- 50D MA
- $3.24
- 200D MA
- $3.55
- Beta
- 0.45
- Avg Volume
- 2.56M
Get TickerSpark's AI analysis on RCKT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 26, 26 | Militello John | other | 51,509 |
| May 26, 26 | Militello John | other | 24,899 |
| May 26, 26 | Militello John | other | 16,061 |
| May 26, 26 | Militello John | other | 15,002 |
| May 26, 26 | Militello John | other | 9,091 |
| May 26, 26 | Militello John | sell | 2,000 |
| May 26, 26 | Militello John | sell | 18,000 |
| May 26, 26 | Militello John | sell | 18,000 |
| May 26, 26 | Militello John | sell | 27,003 |
| May 26, 26 | Militello John | sell | 28,910 |
Our RCKT coverage
Recent articles, reports, and earnings notes.
No research on RCKT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RCKT report →Similar companies
Peers in the same neighborhood.